Researchers found that regorafenib markedly enhanced cisplatin-induced cytotoxicity in lung cancer cells by activating reactive oxygen species-mediated endoplasmic reticulum stress, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase signaling pathways.
[Neoplasia]